Orexigen Therapeutics, Inc.
(Other OTC/NBB : OREX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.02%64.351.0%$559.99m
AMGNAmgen, Inc. 1.21%227.561.3%$484.23m
BIIBBiogen, Inc. -0.15%281.541.4%$395.32m
ILMNIllumina, Inc. 0.29%315.183.5%$328.68m
VRTXVertex Pharmaceuticals, Inc. 0.45%233.021.9%$278.06m
REGNRegeneron Pharmaceuticals, Inc. -0.15%343.552.6%$250.35m
EXASEXACT Sciences Corp. -0.01%90.7024.0%$228.33m
ALXNAlexion Pharmaceuticals, Inc. 1.09%108.142.0%$180.53m
AAgilent Technologies, Inc. 1.10%88.141.6%$138.48m
INCYIncyte Corp. -1.11%75.612.5%$128.22m
SRPTSarepta Therapeutics, Inc. 1.74%119.9814.6%$117.98m
BMRNBioMarin Pharmaceutical, Inc. 0.84%86.614.3%$113.52m
SGENSeattle Genetics, Inc. -0.91%111.906.1%$106.85m
DERMDermira, Inc. -0.24%18.763.8%$85.83m
BLUEbluebird bio, Inc. 0.66%84.5114.2%$84.94m

Company Profile

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.